Compare ETO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETO | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.2M | 482.9M |
| IPO Year | 2004 | 2016 |
| Metric | ETO | BVS |
|---|---|---|
| Price | $28.55 | $8.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 29.1K | ★ 293.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ N/A | $25.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.05 | $5.81 |
| 52 Week High | $31.11 | $11.25 |
| Indicator | ETO | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 33.06 | 56.72 |
| Support Level | $27.05 | $6.42 |
| Resistance Level | $28.77 | $9.01 |
| Average True Range (ATR) | 0.49 | 0.39 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 26.24 | 46.67 |
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.